View from the Rock: KRAS gene mutation in cancer | Genome Engineering

The presence or absence of a KRAS mutation is a factor in the choice of cancer therapies, and Brendan O’Sullivan of the University Hospitals Birmingham NHS Foundation Trust discussed its role at the Planet xMAP 2012 meeting in Monaco, 10-11 October 2012.
Flag this


There are currently no comments. Add a new comment!

Post a comment

You must be logged in to post comments. Login now

Posted by Suzanne Elvidge


Genome Engineering ( started in 2010, and monitors the latest changes and updates in genome engineering, aiming to educate and sometimes to entertain. This platform looks to connect people around the world who are interested in genome engineering. It includes news and in-depth features on genome engineering, and practical tips and tricks, as well as the odd light-hearted look at genome engineering. We rely on you to comment on articles and send in your own, as well as sharing views with your peers, submitting tips and tricks, asking questions and providing answers.

0 people like this

Be the first to like this